| Andrea Elizabeth Badiola, CF-SLP | |
|
1501 Hamburg Tpke, Wayne, NJ 07470-4032 | |
| (973) 800-8515 | |
| Not Available |
| Full Name | Andrea Elizabeth Badiola |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1501 Hamburg Tpke, Wayne, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003375304 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1770942252 (* (Not Available)) | Primary |
| Provider Name | Outreach Physical & Occupational Therapy & Speech Rehabilitation, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1841526399 PECOS PAC ID: 2365582665 Enrollment ID: O20101130000532 |
News Archive
Following the uproar after the release of the controversial Foreign Office memos that suggested that Pope Benedict XVI's visit to UK this September could be marked by the launch of "Benedict" condoms. The Foreign Office document, called "The ideal visit would see...", said the Pope could be invited to open an abortion clinic, launch a range of condoms, singing a charity duet with the Queen and bless a gay marriage. The document raised the issues of child abuse by priests and urged the "sacking" of "dodgy bishops" and opening helplines for abused children.
The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc will launch extensions to its ACTICOAT(TM) Silver Coated Antimicrobial Barrier Dressing portfolio at the upcoming Symposium on Advanced Wound Care Spring meeting April 17-19, 2010, in Orlando, FL. The new dressings will be highlighted at the Smith & Nephew booth, #301.
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that it has enrolled the first patient in a U.S. multi-center Phase 1b dose-escalation trial of its cancer-targeted molecular radiotherapeutic compound (131)I-CLR1404 (HOT) in cancer patients with advanced solid tumors.
Using the intestinal hormone GLP-1 in obesity treatment prevents the loss of bone mass otherwise frequently associated with major weight loss. This is the finding of a new study from the University of Copenhagen, Hvidovre and Glostrup Hospital. According to the researchers behind the study, the results may have a significant bearing on future obesity treatment.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Elizabeth Badiola, CF-SLP 1501 Hamburg Tpke, Wayne, NJ 07470-4032 Ph: (973) 800-8515 | Andrea Elizabeth Badiola, CF-SLP 1501 Hamburg Tpke, Wayne, NJ 07470-4032 Ph: (973) 800-8515 |
News Archive
Following the uproar after the release of the controversial Foreign Office memos that suggested that Pope Benedict XVI's visit to UK this September could be marked by the launch of "Benedict" condoms. The Foreign Office document, called "The ideal visit would see...", said the Pope could be invited to open an abortion clinic, launch a range of condoms, singing a charity duet with the Queen and bless a gay marriage. The document raised the issues of child abuse by priests and urged the "sacking" of "dodgy bishops" and opening helplines for abused children.
The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc will launch extensions to its ACTICOAT(TM) Silver Coated Antimicrobial Barrier Dressing portfolio at the upcoming Symposium on Advanced Wound Care Spring meeting April 17-19, 2010, in Orlando, FL. The new dressings will be highlighted at the Smith & Nephew booth, #301.
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that it has enrolled the first patient in a U.S. multi-center Phase 1b dose-escalation trial of its cancer-targeted molecular radiotherapeutic compound (131)I-CLR1404 (HOT) in cancer patients with advanced solid tumors.
Using the intestinal hormone GLP-1 in obesity treatment prevents the loss of bone mass otherwise frequently associated with major weight loss. This is the finding of a new study from the University of Copenhagen, Hvidovre and Glostrup Hospital. According to the researchers behind the study, the results may have a significant bearing on future obesity treatment.
› Verified 1 days ago
Julia Rossetti, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Pike Drive, Wayne, NJ 07470 Phone: 315-889-1690 Fax: 201-644-3731 | |
Brian's T.e.a.m. Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22 Riverview Dr, C/o Brian's T.e.a.m., Wayne, NJ 07470 Phone: 973-628-0400 Fax: 973-627-1724 | |
Mrs. Leanne Christian, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 48 Lenox Rd, Wayne, NJ 07470 Phone: 973-706-7207 | |
Laura Ann Ksyniak, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 89 Baldwin Ter, Wayne, NJ 07470 Phone: 973-696-3928 | |
Tina Marie Crotty, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1211 Hamburg Tpke, Wayne, NJ 07470 Phone: 973-800-8515 | |
Dr. Jennifer D. Moore, EDD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1211 Hamburg Tpke Ste 224, Wayne, NJ 07470 Phone: 973-800-8515 |